JW PHARMACEUTICAL CORPORATION – Trademark Portfolio

Entity Type: 03

JW PHARMACEUTICAL CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. Currently, 7 trademarks are registered. Notable registered marks include FACOL, XIRCLU, FYRELFI, LYXENFY, and PYNLEZO. The owner is based in SEOUL.

2477 NAMBUSUNHWAN-RO, SEOCHO-GU

SEOUL 137-864 , KR

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

XIRCLU
XIRCLU
Registered 2024
PAMVELTY
PAMVELTY
Registered 2024
LYXENFY
LYXENFY
Registered 2024
ZEFPAIV
ZEFPAIV
Registered 2024
FYRELFI
FYRELFI
Registered 2024
PYNLEZO
PYNLEZO
Registered 2024
FACOL
FACOL
Registered 2015

Trademark Classifications

JW PHARMACEUTICAL CORPORATION's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does JW PHARMACEUTICAL CORPORATION have?

JW PHARMACEUTICAL CORPORATION has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 cancelled.

What trademark classes does JW PHARMACEUTICAL CORPORATION file in?

JW PHARMACEUTICAL CORPORATION files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are JW PHARMACEUTICAL CORPORATION's most well-known trademarks?

JW PHARMACEUTICAL CORPORATION's registered trademark portfolio includes well-known marks such as FACOL, XIRCLU, FYRELFI, LYXENFY, and PYNLEZO. These are among 7 currently registered trademarks in the portfolio.

What is JW PHARMACEUTICAL CORPORATION's trademark registration success rate?

JW PHARMACEUTICAL CORPORATION has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.